GRT-R910

N/A

Report date: 2026/05/13 11:17:42

Base Information

Drug NameGRT-R910

Drug Alias NameSelf-amplifying mRNA vaccineProphylactic samRNA vaccinesChimpanzee Adenovirus serotype 68 - SpikeSelf-Amplifying mRNA - Lipid Nanoparticles - SpikeGRT-R-910 +[8]

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGritstone Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesGritstone Bio Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A